Lexaria Bioscience

(NASDAQ) LEXXW

Current Price$0.00

Market CapN/A

Since IPO (2021)-100%

5 Year-100%

1 Year-100%

1 Month-96%

Lexaria Bioscience Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$368.00K

Net Income (TTM)

$9.53M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

LEXXW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lexaria Bioscience

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Kelowna, NV V1X 2P7, US

LEXXW Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-25%

Net Income Margin

-26%

Return on Equity

-2%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$587.35K

Operating Income

$11.63M

EBITDA

$11.80M

Operating Cash Flow

$10.45M

Capital Expenditure

$24.64K

Free Cash Flow

$10.48M

Cash & ST Invst.

$1.97M

Total Debt

$109.32K

Lexaria Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$20.00K

-88.5%

Gross Profit

$6.57K

-104.2%

Gross Margin

-32.84%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.45M

+46.6%

EBITDA

$1.43M

+47.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$5.18M

-19.4%

Accounts Receivable

$42.03K

-87.3%

Inventory

$0.00

N/A

Long Term Debt

$62.33K

-34.0%

Short Term Debt

$32.06K

+9.3%

Return on Assets

-1.47%

N/A

Return on Invested Capital

-1.47%

N/A

Free Cash Flow

$2.22M

-48.2%

Operating Cash Flow

$2.16M

-44.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

XRTXXORTX Therapeutics Inc.

XRTXXORTX Therapeutics Inc.$2.78-2.80%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.80-9.09%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$2.51+2.03%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.02-20.00%

NCELNewcelX Ltd.

NCELNewcelX Ltd.$3.85-12.70%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$0.13-1.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About LEXXW

What is the current price of Lexaria Bioscience?

Lexaria Bioscience is trading at N/A per share.

What is the 52-week range for Lexaria Bioscience?

Over the past 52 weeks, Lexaria Bioscience has traded between N/A and N/A.

How much debt does Lexaria Bioscience have?

Lexaria Bioscience total debt is unavailable.

How much cash does Lexaria Bioscience have on hand?

Lexaria Bioscience does not have cash on hand data available.

What is Lexaria Bioscience’s dividend yield?

Lexaria Bioscience does not currently have a dividend yield.

Lexaria Bioscience

Lexaria Bioscience Financials at a Glance

LEXXW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lexaria Bioscience

LEXXW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lexaria Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LEXXW

What is the current price of Lexaria Bioscience?

What is the 52-week range for Lexaria Bioscience?

How much debt does Lexaria Bioscience have?

How much cash does Lexaria Bioscience have on hand?

What is Lexaria Bioscience’s dividend yield?

Premium Investing Services